• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Life Science Equipment

TrovaGene Inc

+ Add to Watchlist

TROV:US

3.1800 USD 0.0400 1.24%

As of 16:30:00 ET on 07/25/2014.

Snapshot for TrovaGene Inc (TROV)

Open: 3.1900 Day's Range: 3.1600 - 3.2000 Volume: 13,526
Previous Close: 3.2200 52wk Range: 3.1500 - 10.2699 1-Yr Rtn: -60.10%

Stock Chart for TROV

No chart data available.
  • TROV:US 3.1800
  • 1D
  • 1M
  • 1Y
3.2200
Interactive TROV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TROV

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.8730
Est. EPS (USD) (12/2014) -0.8300
Est. PEG Ratio -
Market Cap (M USD) 60.11
Shares Outstanding (M) 18.90
30 Day Average Volume 55,825
Price/Book (mrq) 3.5057
Price/Sale (ttm) 227.9727
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TROV

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TROV

TrovaGene, Inc. is an applied genomics company. The Company is developing a non-invasive testing technology using transrenal nucleic acid (TrNA) markers for infectious diseases, prenatal testing, early detection of cancer, and monitoring of organ and cell transplantation.

Antonius P Schuh "Tony"Chief Executive OfficerStephen L Zaniboni "Steve"Chief Financial Officer
Mark ErlanderChief Scientific Officer
More Company Profile & Key Executives for TROV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil